vimarsana.com

Latest Breaking News On - Roche rozlytrek - Page 1 : vimarsana.com

Bristol Myers Squibb Wins FDA Approval for Lung Cancer Drug From $4B Deal

FDA approval of Bristol Myers Squibb’s Augtyro covers treatment of patients whose non-small cell lung cancer is driven by the rare ROS1 mutation. The molecule comes from BMS’s 2022 acquisition of Turning Point Therapeutics.

Bristol Myers $4 1B Turning Point buy yields FDA approval for lung cancer drug Augtyro

Bristol Myers $4 1B Turning Point buy yields FDA approval for lung cancer drug Augtyro
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

vimarsana © 2020. All Rights Reserved.